Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Why CEL-SCI (CVM) Shares Are Down 20%

CEL-SCI Corporation (NASDAQ: CVM) shares are trading lower by 21.3% to $2.25 Tuesday morning after the company priced its public offering of 2.5 million shares at $2.00 per share.
byHenry Khederian
July 18, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

CEL-SCI Corporation (NASDAQ:CVM) shares are trading lower by 21.3% to $2.25 Tuesday morning after the company priced its public offering of 2.5 million shares at $2.00 per share.

The offering is expected to generate gross proceeds of $5 million. The closing is scheduled for July 20, subject to customary conditions. The net proceeds will fund the development of Multikine and support general corporate purposes.

ThinkEquity is the sole book-running manager for the offering.

See Also: What’s Going On With Wells Fargo Shares

According to data from Benzinga Pro, CVM has a 52-week high of $5.42 and a 52-week low of $1.86.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Veru Announces FDA Has Rescheduled The Meeting Date To Nov. 9 For The Advisory Committee To Review Emergency Use Authorization For Sabizabulin For Hospitalized COVID-19 Patients At High Risk For Acute Respiratory Distress Syndrome; No Change In Agenda

By Benzinga Newsdesk
September 19, 12:19 PM
MIAMI, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for the management of breast

VERU